Details for: HDAC2

Gene ID: 3066

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: HDAC2

Ensembl ID: ENSG00000196591

Description: histone deacetylase 2

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 64.29
    rCSI 58.06%
    PRS 19.31
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 61.74
    rCSI 71.3%
    PRS 18.6
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 55.5
    rCSI 71.23%
    PRS 20.55
  • peripheral nervous system neuron CL2000032
    CSI 51.18
    rCSI 69.73%
    PRS 18.82
  • common myeloid progenitor CL0000049
    CSI 44.49
    rCSI 35.98%
    PRS 21.44
  • fraction A pre-pro B cell CL0002045
    CSI 40.91
    rCSI 46.83%
    PRS 42.68
  • radial glial cell CL0000681
    CSI 38.04
    rCSI 52.84%
    PRS 21.72
  • mesodermal cell CL0000222
    CSI 37.06
    rCSI 44.49%
    PRS 20.79
  • intestinal epithelial cell CL0002563
    CSI 33.08
    rCSI 34.58%
    PRS 22.24
  • early lymphoid progenitor CL0000936
    CSI 32.3
    rCSI 28.37%
    PRS 24.63
  • common dendritic progenitor CL0001029
    CSI 31.99
    rCSI 40.15%
    PRS 27.68
  • neural crest cell CL0011012
    CSI 31.08
    rCSI 24.57%
    PRS 14.66
  • hematopoietic stem cell CL0000037
    CSI 25.6
    rCSI 17.01%
    PRS 25.53
  • enteric smooth muscle cell CL0002504
    CSI 21.52
    rCSI 30.7%
    PRS 23.94
  • stem cell CL0000034
    CSI 20.4
    rCSI 19.67%
    PRS 15.51
  • promyelocyte CL0000836
    CSI 19.76
    rCSI 28.51%
    PRS 30
  • large pre-B-II cell CL0000957
    CSI 17.73
    rCSI 50.63%
    PRS 35.63
  • granulocyte monocyte progenitor cell CL0000557
    CSI 17.13
    rCSI 14.84%
    PRS 24.11
  • transit amplifying cell of colon CL0009011
    CSI 16.97
    rCSI 19.93%
    PRS 24.54
  • placental villous trophoblast CL2000060
    CSI 16.4
    rCSI 25.34%
    PRS 19.91
  • epithelial cell of lung CL0000082
    CSI 15.52
    rCSI 12.86%
    PRS 20.23
  • pro-B cell CL0000826
    CSI 14.99
    rCSI 12.42%
    PRS 21.69
  • common lymphoid progenitor CL0000051
    CSI 13.92
    rCSI 18.6%
    PRS 40.23
  • double negative thymocyte CL0002489
    CSI 12.97
    rCSI 9.02%
    PRS 25.65
  • forebrain radial glial cell CL0013000
    CSI 12.62
    rCSI 40.5%
    PRS 30.11
  • pancreatic acinar cell CL0002064
    CSI 12.22
    rCSI 16.24%
    PRS 23.37
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 12.18
    rCSI 12.41%
    PRS 30.48
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 12.01
    rCSI 35.45%
    PRS 25.4
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 11.52
    rCSI 10.65%
    PRS 38.42
  • melanocyte CL0000148
    CSI 11.28
    rCSI 8.35%
    PRS 18.45
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 11.27
    rCSI 43.85%
    PRS 35
  • enterocyte CL0000584
    CSI 10.8
    rCSI 17.41%
    PRS 32.25
  • alpha-beta T cell CL0000789
    CSI 10.5
    rCSI 12.31%
    PRS 29.42
  • epithelial cell CL0000066
    CSI 10.32
    rCSI 15.86%
    PRS 28.93
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 10.17
    rCSI 52.53%
    PRS 41.13
  • mesangial cell CL0000650
    CSI 9.98
    rCSI 40.68%
    PRS 30.41
  • enteroendocrine cell CL0000164
    CSI 9.81
    rCSI 13.41%
    PRS 23.74
  • erythrocyte CL0000232
    CSI 9.46
    rCSI 21.46%
    PRS 28.38
  • endothelial cell of placenta CL0009092
    CSI 9.41
    rCSI 46.36%
    PRS 28.77
  • primitive red blood cell CL0002355
    CSI 9.39
    rCSI 50.69%
    PRS 36.4
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 9.19
    rCSI 11.1%
    PRS 25.66
  • transit amplifying cell CL0009010
    CSI 9.13
    rCSI 13.96%
    PRS 34.36
  • progenitor cell CL0011026
    CSI 9.05
    rCSI 19.26%
    PRS 32.72
  • neural cell CL0002319
    CSI 8.87
    rCSI 33.46%
    PRS 27.59
  • Cajal-Retzius cell CL0000695
    CSI 8.79
    rCSI 68.9%
    PRS 41.55
  • glutamatergic neuron CL0000679
    CSI 8.71
    rCSI 17.9%
    PRS 21.09
  • myeloid leukocyte CL0000766
    CSI 8.67
    rCSI 8%
    PRS 22.22
  • Schwann cell CL0002573
    CSI 8.65
    rCSI 24.58%
    PRS 24.3
  • eosinophil CL0000771
    CSI 8.43
    rCSI 55.34%
    PRS 52.04
  • interneuron CL0000099
    CSI 8.33
    rCSI 16.72%
    PRS 15.78
  • midbrain dopaminergic neuron CL2000097
    CSI 8.29
    rCSI 53.08%
    PRS 32.7
  • extravillous trophoblast CL0008036
    CSI 8.28
    rCSI 10.24%
    PRS 18.68
  • epithelial cell of lower respiratory tract CL0002632
    CSI 8.04
    rCSI 6.24%
    PRS 20.49
  • interstitial cell of Cajal CL0002088
    CSI 7.62
    rCSI 9.7%
    PRS 24.72
  • thymocyte CL0000893
    CSI 7.59
    rCSI 26.97%
    PRS 60.86
  • vascular associated smooth muscle cell CL0000359
    CSI 7.56
    rCSI 24.51%
    PRS 25.6
  • hepatic stellate cell CL0000632
    CSI 7.43
    rCSI 27.82%
    PRS 17.97
  • myofibroblast cell CL0000186
    CSI 7.42
    rCSI 10.28%
    PRS 29.9
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 7.38
    rCSI 14.72%
    PRS 35.6
  • cerebral cortex endothelial cell CL1001602
    CSI 7.35
    rCSI 12.72%
    PRS 16.3
  • fallopian tube secretory epithelial cell CL4030006
    CSI 7.32
    rCSI 7.05%
    PRS 22.08
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 7.17
    rCSI 20.57%
    PRS 31.94
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 7.05
    rCSI 5.65%
    PRS 37.9
  • intestine goblet cell CL0019031
    CSI 6.85
    rCSI 6.08%
    PRS 21.51
  • goblet cell CL0000160
    CSI 6.84
    rCSI 6.47%
    PRS 22.42
  • keratinocyte CL0000312
    CSI 6.68
    rCSI 5.6%
    PRS 25.3
  • paneth cell CL0000510
    CSI 6.6
    rCSI 9.74%
    PRS 33.18
  • mesenchymal cell CL0008019
    CSI 6.58
    rCSI 16.72%
    PRS 21.39
  • elicited macrophage CL0000861
    CSI 6.55
    rCSI 6.01%
    PRS 25.05
  • colon epithelial cell CL0011108
    CSI 6.32
    rCSI 6.62%
    PRS 19.93
  • alternatively activated macrophage CL0000890
    CSI 6.23
    rCSI 7.83%
    PRS 32.63
  • brush cell of tracheobronchial tree CL0002075
    CSI 6.21
    rCSI 18.41%
    PRS 29.79
  • cerebral cortex neuron CL0010012
    CSI 6.18
    rCSI 25.18%
    PRS 21.73
  • naive T cell CL0000898
    CSI 6.13
    rCSI 4.26%
    PRS 30.16
  • BEST4+ enteroycte CL4030026
    CSI 6
    rCSI 7.46%
    PRS 22.72
  • glioblast CL0000030
    CSI 5.98
    rCSI 9.54%
    PRS 18.24
  • multi-ciliated epithelial cell CL0005012
    CSI 5.94
    rCSI 5.93%
    PRS 18.23
  • colonocyte CL1000347
    CSI 5.93
    rCSI 8.5%
    PRS 28.68
  • hematopoietic precursor cell CL0008001
    CSI 5.81
    rCSI 5.98%
    PRS 34.51
  • inhibitory interneuron CL0000498
    CSI 5.76
    rCSI 13.3%
    PRS 17.2
  • granulocyte CL0000094
    CSI 5.73
    rCSI 8.75%
    PRS 27.66
  • Kupffer cell CL0000091
    CSI 5.5
    rCSI 12.59%
    PRS 20.79
  • kidney loop of Henle thin ascending limb epithelial cell CL1001107
    CSI 5.41
    rCSI 13.99%
    PRS 19.83
  • fibroblast of lung CL0002553
    CSI 5.38
    rCSI 5%
    PRS 21.38
  • conventional dendritic cell CL0000990
    CSI 5.36
    rCSI 4.47%
    PRS 52.94
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 5.35
    rCSI 6.66%
    PRS 11.82
  • secretory cell CL0000151
    CSI 5.25
    rCSI 5.48%
    PRS 21.88
  • kidney epithelial cell CL0002518
    CSI 5.22
    rCSI 9.96%
    PRS 45.53
  • basophil mast progenitor cell CL0002028
    CSI 5.19
    rCSI 27.68%
    PRS 66.43
  • precursor B cell CL0000817
    CSI 5.08
    rCSI 4.45%
    PRS 28.48
  • myeloid dendritic cell CL0000782
    CSI 4.95
    rCSI 7.17%
    PRS 32.25
  • respiratory epithelial cell CL0002368
    CSI 4.88
    rCSI 30.11%
    PRS 60.97
  • basal cell CL0000646
    CSI 4.88
    rCSI 6.52%
    PRS 23.38
  • type EC enteroendocrine cell CL0000577
    CSI 4.86
    rCSI 17.26%
    PRS 34.5
  • ciliated cell CL0000064
    CSI 4.81
    rCSI 7.79%
    PRS 21.56
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 4.68
    rCSI 8.84%
    PRS 44.36
  • mesenchymal stem cell CL0000134
    CSI 4.61
    rCSI 50.52%
    PRS 37.45
  • neuroplacodal cell CL0000032
    CSI 4.53
    rCSI 41.92%
    PRS 52.26
  • mammary gland epithelial cell CL0002327
    CSI 4.53
    rCSI 15.88%
    PRS 36.67
  • neuroendocrine cell CL0000165
    CSI 4.52
    rCSI 17.5%
    PRS 41.2
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI -0.6
    rCSI -2.0%
    PRS 11.9%
  • astrocyte of the cerebral cortex CL0002605
    CSI -0.4
    rCSI -0.9%
    PRS 13.2%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.1
    rCSI 0.4%
    PRS 40.8%
  • retinal ganglion cell CL0000740
    CSI 0.1
    rCSI 0.3%
    PRS 15.2%
  • epithelial cell of urethra CL1000296
    CSI 0.2
    rCSI 3.8%
    PRS 55.7%
  • central nervous system neuron CL2000029
    CSI 0.2
    rCSI 1.3%
    PRS 12.8%
  • intestinal crypt stem cell of colon CL0009043
    CSI 0.2
    rCSI 1.5%
    PRS 38.6%
  • respiratory goblet cell CL0002370
    CSI 0.2
    rCSI 2.4%
    PRS 40.2%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 0.2
    rCSI 5.7%
    PRS 59.4%
  • cytotoxic T cell CL0000910
    CSI 0.3
    rCSI 1.6%
    PRS 31.3%
  • cerebral cortex pyramidal neuron CL4023111
    CSI 0.3
    rCSI 1.8%
    PRS 50.8%
  • luminal cell of prostate epithelium CL0002340
    CSI 0.3
    rCSI 1.7%
    PRS 37.2%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.3
    rCSI 5.2%
    PRS 50.0%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.3
    rCSI 1.8%
    PRS 48.0%
  • H2 horizontal cell CL0004218
    CSI 0.4
    rCSI 2.0%
    PRS 23.1%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.4
    rCSI 1.1%
    PRS 16.2%
  • mature alpha-beta T cell CL0000791
    CSI 0.4
    rCSI 1.5%
    PRS 36.7%
  • basal cell of epithelium of trachea CL1000348
    CSI 0.5
    rCSI 3.2%
    PRS 55.7%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 0.5
    rCSI 1.9%
    PRS 13.0%
  • bronchial goblet cell CL1000312
    CSI 0.6
    rCSI 2.4%
    PRS 44.0%
  • mature T cell CL0002419
    CSI 0.6
    rCSI 0.5%
    PRS 31.4%
  • glandular epithelial cell CL0000150
    CSI 0.6
    rCSI 1.6%
    PRS 41.1%
  • CD34-positive, CD56-positive, CD117-positive common innate lymphoid precursor, human CL0001074
    CSI 0.7
    rCSI 7.5%
    PRS 67.9%
  • dendritic cell, human CL0001056
    CSI 0.7
    rCSI 1.0%
    PRS 25.6%
  • forebrain neuroblast CL1000042
    CSI 0.7
    rCSI 7.2%
    PRS 90.4%
  • stromal cell of ovary CL0002132
    CSI 0.7
    rCSI 2.0%
    PRS 34.9%
  • myeloid dendritic cell, human CL0001057
    CSI 0.8
    rCSI 4.2%
    PRS 60.2%
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 0.8
    rCSI 1.3%
    PRS 12.6%
  • L6b glutamatergic cortical neuron CL4023038
    CSI 0.8
    rCSI 2.4%
    PRS 13.5%
  • pancreatic PP cell CL0002275
    CSI 0.8
    rCSI 3.2%
    PRS 36.2%
  • M cell of gut CL0000682
    CSI 0.8
    rCSI 0.9%
    PRS 36.2%
  • endothelial cell of uterus CL0009095
    CSI 0.8
    rCSI 6.0%
    PRS 54.1%
  • Langerhans cell CL0000453
    CSI 0.8
    rCSI 1.3%
    PRS 37.1%
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 0.9
    rCSI 2.8%
    PRS 14.5%
  • corneal epithelial cell CL0000575
    CSI 0.9
    rCSI 2.5%
    PRS 37.2%
  • glycinergic amacrine cell CL4030028
    CSI 0.9
    rCSI 2.4%
    PRS 21.5%
  • squamous epithelial cell CL0000076
    CSI 0.9
    rCSI 2.2%
    PRS 26.3%
  • retinal cone cell CL0000573
    CSI 0.9
    rCSI 1.5%
    PRS 16.3%
  • Purkinje cell CL0000121
    CSI 0.9
    rCSI 12.3%
    PRS 72.2%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 1.0
    rCSI 1.6%
    PRS 12.7%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 1.0
    rCSI 1.3%
    PRS 30.5%
  • hepatocyte CL0000182
    CSI 1.0
    rCSI 1.8%
    PRS 19.7%
  • lung goblet cell CL1000143
    CSI 1.0
    rCSI 11.3%
    PRS 61.4%
  • brush cell CL0002204
    CSI 1.0
    rCSI 2.0%
    PRS 50.2%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.0
    rCSI 2.9%
    PRS 32.9%
  • intermediate monocyte CL0002393
    CSI 1.1
    rCSI 1.6%
    PRS 21.7%
  • foveolar cell of stomach CL0002179
    CSI 1.1
    rCSI 2.2%
    PRS 33.7%
  • retinal rod cell CL0000604
    CSI 1.1
    rCSI 1.9%
    PRS 20.8%
  • tracheal goblet cell CL1000329
    CSI 1.1
    rCSI 2.4%
    PRS 40.9%
  • enteroendocrine cell of colon CL0009042
    CSI 1.1
    rCSI 5.1%
    PRS 51.4%
  • germinal center B cell CL0000844
    CSI 1.2
    rCSI 3.6%
    PRS 47.2%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 1.2
    rCSI 6.1%
    PRS 28.2%
  • Hofbauer cell CL3000001
    CSI 1.2
    rCSI 2.3%
    PRS 27.0%
  • ON-bipolar cell CL0000749
    CSI 1.3
    rCSI 2.0%
    PRS 25.2%
  • deuterosomal cell CL4033044
    CSI 1.3
    rCSI 4.5%
    PRS 33.6%
  • basal cell of epidermis CL0002187
    CSI 1.4
    rCSI 2.4%
    PRS 17.1%
  • amacrine cell CL0000561
    CSI 1.4
    rCSI 4.0%
    PRS 16.4%
  • IgG plasma cell CL0000985
    CSI 1.4
    rCSI 1.6%
    PRS 36.9%
  • pancreatic A cell CL0000171
    CSI 1.4
    rCSI 1.5%
    PRS 22.7%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 1.4
    rCSI 2.6%
    PRS 32.4%
  • mononuclear phagocyte CL0000113
    CSI 1.4
    rCSI 3.1%
    PRS 24.3%
  • megakaryocyte CL0000556
    CSI 1.5
    rCSI 6.4%
    PRS 36.8%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 1.5
    rCSI 1.6%
    PRS 24.0%
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 1.5
    rCSI 8.7%
    PRS 13.2%
  • pancreatic epsilon cell CL0005019
    CSI 1.5
    rCSI 6.9%
    PRS 45.7%
  • type B pancreatic cell CL0000169
    CSI 1.5
    rCSI 3.3%
    PRS 19.8%
  • lung endothelial cell CL1001567
    CSI 1.5
    rCSI 3.5%
    PRS 48.0%
  • retina horizontal cell CL0000745
    CSI 1.5
    rCSI 2.3%
    PRS 19.7%
  • nasal mucosa goblet cell CL0002480
    CSI 1.5
    rCSI 1.8%
    PRS 30.7%
  • regular atrial cardiac myocyte CL0002129
    CSI 1.5
    rCSI 4.9%
    PRS 22.2%
  • OFF-bipolar cell CL0000750
    CSI 1.6
    rCSI 2.1%
    PRS 32.8%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.6
    rCSI 1.2%
    PRS 19.9%
  • cardiac muscle cell CL0000746
    CSI 1.6
    rCSI 2.3%
    PRS 16.5%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.6
    rCSI 4.0%
    PRS 12.4%
  • mucous neck cell CL0000651
    CSI 1.7
    rCSI 2.4%
    PRS 33.5%
  • innate lymphoid cell CL0001065
    CSI 1.7
    rCSI 3.5%
    PRS 31.7%
  • neural progenitor cell CL0011020
    CSI 1.7
    rCSI 7.5%
    PRS 19.9%
  • basal cell of prostate epithelium CL0002341
    CSI 1.7
    rCSI 4.9%
    PRS 44.2%
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 1.7
    rCSI 1.7%
    PRS 55.4%
  • choroid plexus epithelial cell CL0000706
    CSI 1.8
    rCSI 2.9%
    PRS 16.4%
  • group 3 innate lymphoid cell CL0001071
    CSI 1.8
    rCSI 1.4%
    PRS 22.7%
  • respiratory hillock cell CL4030023
    CSI 1.8
    rCSI 3.2%
    PRS 35.2%
  • glial cell CL0000125
    CSI 1.8
    rCSI 6.9%
    PRS 20.6%
  • syncytiotrophoblast cell CL0000525
    CSI 1.8
    rCSI 5.3%
    PRS 38.8%
  • tracheobronchial serous cell CL0019001
    CSI 1.8
    rCSI 7.9%
    PRS 38.6%
  • cell of skeletal muscle CL0000188
    CSI 1.8
    rCSI 20.0%
    PRS 74.0%
  • small intestine goblet cell CL1000495
    CSI 1.8
    rCSI 4.0%
    PRS 28.5%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 1.9
    rCSI 8.5%
    PRS 63.8%
  • club cell CL0000158
    CSI 1.9
    rCSI 2.8%
    PRS 24.3%
  • mesenchymal lymphangioblast CL0005021
    CSI 1.9
    rCSI 49.9%
    PRS 71.6%
  • enteroendocrine cell of small intestine CL0009006
    CSI 2.0
    rCSI 4.4%
    PRS 32.2%
  • megakaryocyte progenitor cell CL0000553
    CSI 2.0
    rCSI 37.3%
    PRS 58.0%
  • cerebellar granule cell CL0001031
    CSI 2.1
    rCSI 3.0%
    PRS 19.7%
  • rod bipolar cell CL0000751
    CSI 2.1
    rCSI 3.7%
    PRS 17.6%
  • class switched memory B cell CL0000972
    CSI 2.1
    rCSI 1.6%
    PRS 35.7%
  • mucus secreting cell CL0000319
    CSI 2.1
    rCSI 3.4%
    PRS 27.4%
  • lung ciliated cell CL1000271
    CSI 2.1
    rCSI 2.5%
    PRS 15.7%
  • retinal blood vessel endothelial cell CL0002585
    CSI 2.2
    rCSI 3.4%
    PRS 23.4%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 2.2
    rCSI 6.3%
    PRS 24.1%
  • mature B cell CL0000785
    CSI 2.2
    rCSI 1.9%
    PRS 26.9%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary Analyzed for its expression specificity (CSI Z-SCORE), histone deacetylase 2 ([HDAC2](/details-gene/3066)) demonstrates a broad and non-specific expression profile, suggesting a fundamental and ubiquitous role in chromatin regulation across diverse cell lineages. Its function is not as a defining marker for a specific cell type but rather as a core component of the transcriptional machinery responsible for epigenetic modulation. Evidence points to its consistent expression in a wide range of progenitor and stem cells, implicating it in the fundamental processes of development, cell fate specification, and the maintenance of cellular identity. ## Cellular Roles and Expression Landscape The expression analysis, based on specificity (CSI Z-SCORE), reveals that [HDAC2](/details-gene/3066) does not serve as a unique identifier for any particular cell population. The uniformly low CSI (Z-SCORE) of 0.00 and non-significant p-values across all top-ranked cells indicate that its expression is widespread rather than concentrated in a specific cell type. This pattern is characteristic of genes involved in essential, or 'housekeeping,' cellular functions. Despite the lack of specificity, the data highlights its consistent presence in a variety of progenitor and stem cell populations within the **Overall** context. These include hematopoietic precursors such as [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050), [common myeloid progenitor](/details-cell/CL0000049), and [hematopoietic stem cell](/details-cell/CL0000037), as well as neural precursors like [neuroblast (sensu Vertebrata)](/details-cell/CL0000031) and [radial glial cell](/details-cell/CL0000681). This broad expression in undifferentiated and actively differentiating cells underscores its likely role in governing the dynamic changes in gene expression required for lineage commitment and development. The consistent expression across these diverse progenitors suggests that [HDAC2](/details-gene/3066) is a key enzymatic component for modulating chromatin accessibility, a process crucial for both maintaining pluripotency and enabling differentiation programs. ## Pathways and Molecular Function The functional annotations for [HDAC2](/details-gene/3066) strongly support its role as a master epigenetic regulator, which explains its broad cellular expression pattern. As a histone deacetylase, its primary molecular function is to remove acetyl groups from lysine residues on histones, leading to more compact chromatin and transcriptional repression. This is captured by Gene Ontology terms such as '[Histone deacetylase activity](/details-go/GO:0004407)' and its localization to the '[Nucleus](/details-go/GO:0005634)' and '[Chromatin](/details-go/GO:0000785)'. [HDAC2](/details-gene/3066) is a core component of several major transcriptional repressor complexes, including the NuRD and Sin3 complexes, as supported by published research (PubMed: [10904264](https://pubmed.ncbi.nlm.nih.gov/10904264/)) and GO annotations '[Nurd complex](/details-go/GO:0016581)' and '[Sin3-type complex](/details-go/GO:0070822)'. These complexes are critical for global gene regulation. Its involvement in high-level biological processes is extensive, as shown by its annotation in Reactome pathways like '[Chromatin modifying enzymes](https://reactome.org/content/detail/R-HSA-3247509)', '[Gene expression (transcription)](https://reactome.org/content/detail/R-HSA-74160)', and '[Developmental biology](https://reactome.org/content/detail/R-HSA-1266738)'. The breadth of these pathways aligns perfectly with the expression data, indicating that [HDAC2](/details-gene/3066) is a pleiotropic regulator integral to the cellular machinery of numerous, if not all, cell types, particularly during dynamic developmental states. Its interaction with key transcription factors like YY1 (PubMed: [8917507](https://pubmed.ncbi.nlm.nih.gov/8917507/)) and its role in regulating TP53 activity (Reactome: '[R-HSA-5633007](https://reactome.org/content/detail/R-HSA-5633007)') further cement its status as a central hub in the gene regulatory network. ## Research Directions The ubiquitous expression of [HDAC2](/details-gene/3066), particularly in progenitor cells, suggests that its function is highly context-dependent, likely dictated by its protein interaction partners rather than its sheer presence. Future research should focus on dissecting the composition and targets of HDAC2-containing complexes in different cell lineages. ### Testable Hypotheses: 1. **Hypothesis 1: In hematopoietic progenitors, [HDAC2](/details-gene/3066) maintains stemness by forming a complex with lineage-specific transcription factors to repress key differentiation genes.** The consistent expression in [hematopoietic stem cell](/details-cell/CL0000037) and other progenitors suggests a role in preventing premature differentiation. * **Experimental Approach:** Perform conditional knockout or CRISPRi-mediated knockdown of `HDAC2` in primary human CD34+ hematopoietic stem and progenitor cells. Analyze the resulting changes in differentiation trajectories towards myeloid and lymphoid lineages using single-cell RNA sequencing and flow cytometry. Concurrently, use ChIP-seq to identify genomic sites where HDAC2 binding is lost and correlate these with upregulated differentiation-associated genes. 2. **Hypothesis 2: The enzymatic activity of [HDAC2](/details-gene/3066) is differentially regulated in neural versus hematopoietic progenitors to control distinct developmental programs.** While expressed in both [neuroblasts](/details-cell/CL0000031) and [common myeloid progenitors](/details-cell/CL0000049), its functional output is likely tailored to each lineage. * **Experimental Approach:** Employ proximity-dependent biotinylation (BioID) in both a neural progenitor cell line and a hematopoietic progenitor cell line to identify differential protein interactors of [HDAC2](/details-gene/3066). This will reveal lineage-specific complex compositions that can be validated by co-immunoprecipitation. 3. **Hypothesis 3: Cellular stress signals, such as oxidative stress or DNA damage, cause a genome-wide redistribution of [HDAC2](/details-gene/3066) binding in stem cells to prioritize survival and repair pathways over differentiation.** This is suggested by its annotated roles in responding to stimuli like hydrogen peroxide ('[GO:0070301](https://www.ebi.ac.uk/QuickGO/term/GO:0070301)') and its association with DNA repair proteins (PubMed: [10545197](https://pubmed.ncbi.nlm.nih.gov/10545197/)). * **Experimental Approach:** Expose a [stem cell](/details-cell/CL0000034) population (e.g., iPSCs) to a sublethal dose of H2O2. Perform time-course ChIP-seq for [HDAC2](/details-gene/3066) to map its dynamic relocalization from developmental gene promoters to stress-response gene loci. Correlate these binding changes with transcriptional output measured by RNA-seq. ### Therapeutic Potential: The central role of [HDAC2](/details-gene/3066) in gene regulation has made it a target for therapeutic intervention, particularly in cancer, where epigenetic dysregulation is common. Non-specific HDAC inhibitors (HDACi) are already in clinical use. However, the ubiquitous expression of [HDAC2](/details-gene/3066) leads to significant off-target effects. The therapeutic frontier lies in developing strategies to target HDAC2 activity in a cell-type or disease-specific manner. This could involve creating inhibitors that disrupt specific protein-protein interactions (e.g., blocking HDAC2 from binding to an oncogenic transcription factor) rather than its catalytic site, or developing cell-type-specific delivery systems for existing HDACi. Such approaches could increase efficacy while minimizing the toxicity associated with broad epigenetic modulation.

Genular Protein ID: 2675874660

Symbol: HDAC2_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 8917507

Title: Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3.

PubMed ID: 8917507

DOI: 10.1073/pnas.93.23.12845

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 14574404

Title: The DNA sequence and analysis of human chromosome 6.

PubMed ID: 14574404

DOI: 10.1038/nature02055

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 10545197

Title: Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4.

PubMed ID: 10545197

DOI: 10.1021/bi991614n

PubMed ID: 10644367

Title: A role for SKIP in EBNA2 activation of CBF1-repressed promoters.

PubMed ID: 10644367

DOI: 10.1128/jvi.74.4.1939-1947.2000

PubMed ID: 10888872

Title: DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci.

PubMed ID: 10888872

DOI: 10.1038/77023

PubMed ID: 10904264

Title: NuRD and SIN3 histone deacetylase complexes in development.

PubMed ID: 10904264

DOI: 10.1016/s0168-9525(00)02066-7

PubMed ID: 11331609

Title: Sharp, an inducible cofactor that integrates nuclear receptor repression and activation.

PubMed ID: 11331609

DOI: 10.1101/gad.871201

PubMed ID: 11533236

Title: ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.

PubMed ID: 11533236

DOI: 10.1128/mcb.21.19.6470-6483.2001

PubMed ID: 11739383

Title: Isolation and characterization of a novel class II histone deacetylase, HDAC10.

PubMed ID: 11739383

DOI: 10.1074/jbc.m108055200

PubMed ID: 12176973

Title: The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2.

PubMed ID: 12176973

DOI: 10.1074/jbc.c200378200

PubMed ID: 12140263

Title: Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.

PubMed ID: 12140263

DOI: 10.1242/jcs.115.16.3319

PubMed ID: 12402037

Title: Acetylation inactivates the transcriptional repressor BCL6.

PubMed ID: 12402037

DOI: 10.1038/ng1018

PubMed ID: 14633989

Title: Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene.

PubMed ID: 14633989

DOI: 10.1093/emboj/cdg595

PubMed ID: 12670868

Title: Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1.

PubMed ID: 12670868

DOI: 10.1101/gad.252103

PubMed ID: 12493763

Title: A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.

PubMed ID: 12493763

DOI: 10.1074/jbc.m208992200

PubMed ID: 12724404

Title: Identification and characterization of three new components of the mSin3A corepressor complex.

PubMed ID: 12724404

DOI: 10.1128/mcb.23.10.3456-3467.2003

PubMed ID: 15456770

Title: The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.

PubMed ID: 15456770

DOI: 10.1074/jbc.m406831200

PubMed ID: 15060175

Title: Multiple domains of the receptor-interacting protein 140 contribute to transcription inhibition.

PubMed ID: 15060175

DOI: 10.1093/nar/gkh524

PubMed ID: 15701600

Title: MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.

PubMed ID: 15701600

DOI: 10.1074/jbc.m413492200

PubMed ID: 15927959

Title: Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein.

PubMed ID: 15927959

DOI: 10.1074/jbc.m413687200

PubMed ID: 17081983

Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

PubMed ID: 17081983

DOI: 10.1016/j.cell.2006.09.026

PubMed ID: 16428440

Title: MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties.

PubMed ID: 16428440

DOI: 10.1128/mcb.26.3.843-851.2006

PubMed ID: 16820529

Title: SAP30L interacts with members of the Sin3A corepressor complex and targets Sin3A to the nucleolus.

PubMed ID: 16820529

DOI: 10.1093/nar/gkl401

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 19061646

Title: CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation.

PubMed ID: 19061646

DOI: 10.1016/j.molcel.2008.10.025

PubMed ID: 18212045

Title: CtBP is an essential corepressor for BCL6 autoregulation.

PubMed ID: 18212045

DOI: 10.1128/mcb.01400-07

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 18757745

Title: RCS1, a substrate of APC/C, controls the metaphase to anaphase transition.

PubMed ID: 18757745

DOI: 10.1073/pnas.0709227105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19433865

Title: Endosomal adaptor proteins APPL1 and APPL2 are novel activators of beta-catenin/TCF-mediated transcription.

PubMed ID: 19433865

DOI: 10.1074/jbc.m109.007237

PubMed ID: 19343227

Title: FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4.

PubMed ID: 19343227

DOI: 10.1371/journal.pone.0005071

PubMed ID: 19182791

Title: Chfr is linked to tumour metastasis through the downregulation of HDAC1.

PubMed ID: 19182791

DOI: 10.1038/ncb1837

PubMed ID: 19729656

Title: Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate.

PubMed ID: 19729656

DOI: 10.1126/science.1176709

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20523938

Title: CDK2AP1/DOC-1 is a bona fide subunit of the Mi-2/NuRD complex.

PubMed ID: 20523938

DOI: 10.1039/c004108d

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21965678

Title: SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function.

PubMed ID: 21965678

DOI: 10.1074/jbc.m111.267237

PubMed ID: 21914818

Title: A BEN-domain-containing protein associates with heterochromatin and represses transcription.

PubMed ID: 21914818

DOI: 10.1242/jcs.086603

PubMed ID: 21549307

Title: Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.

PubMed ID: 21549307

DOI: 10.1016/j.molcel.2011.02.036

PubMed ID: 21573134

Title: Nuclear cGMP-dependent kinase regulates gene expression via activity-dependent recruitment of a conserved histone deacetylase complex.

PubMed ID: 21573134

DOI: 10.1371/journal.pgen.1002065

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 22926524

Title: RBB, a novel transcription repressor, represses the transcription of HDM2 oncogene.

PubMed ID: 22926524

DOI: 10.1038/onc.2012.386

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 25218447

Title: Uncovering global SUMOylation signaling networks in a site-specific manner.

PubMed ID: 25218447

DOI: 10.1038/nsmb.2890

PubMed ID: 24970816

Title: The subcellular distribution and function of MTA1 in cancer differentiation.

PubMed ID: 24970816

DOI: 10.18632/oncotarget.2095

PubMed ID: 25772364

Title: SUMO-2 orchestrates chromatin modifiers in response to DNA damage.

PubMed ID: 25772364

DOI: 10.1016/j.celrep.2015.02.033

PubMed ID: 25593309

Title: Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.

PubMed ID: 25593309

DOI: 10.1101/gad.252189.114

PubMed ID: 25755297

Title: System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.

PubMed ID: 25755297

DOI: 10.1074/mcp.o114.044792

PubMed ID: 28497810

Title: Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription.

PubMed ID: 28497810

DOI: 10.1038/cr.2017.68

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

PubMed ID: 28977666

Title: CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

PubMed ID: 28977666

DOI: 10.1093/nar/gkx711

PubMed ID: 29192674

Title: Landscape of the regulatory elements for lysine 2-hydroxyisobutyrylation pathway.

PubMed ID: 29192674

DOI: 10.1038/cr.2017.149

PubMed ID: 32051553

Title: The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.

PubMed ID: 32051553

DOI: 10.1038/s41388-020-1206-7

PubMed ID: 33283408

Title: Cross-linking mass spectrometry reveals the structural topology of peripheral NuRD subunits relative to the core complex.

PubMed ID: 33283408

DOI: 10.1111/febs.15650

PubMed ID: 20392638

Title: Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides.

PubMed ID: 20392638

DOI: 10.1016/j.bmcl.2010.03.091

PubMed ID: 37137925

Title: Mechanism of assembly, activation and lysine selection by the SIN3B histone deacetylase complex.

PubMed ID: 37137925

DOI: 10.1038/s41467-023-38276-0

Sequence Information:

  • Length: 488
  • Mass: 55364
  • Checksum: 775419CCCDAE07FA
  • Sequence:
  • MAYSQGGGKK KVCYYYDGDI GNYYYGQGHP MKPHRIRMTH NLLLNYGLYR KMEIYRPHKA 
    TAEEMTKYHS DEYIKFLRSI RPDNMSEYSK QMQRFNVGED CPVFDGLFEF CQLSTGGSVA 
    GAVKLNRQQT DMAVNWAGGL HHAKKSEASG FCYVNDIVLA ILELLKYHQR VLYIDIDIHH 
    GDGVEEAFYT TDRVMTVSFH KYGEYFPGTG DLRDIGAGKG KYYAVNFPMR DGIDDESYGQ 
    IFKPIISKVM EMYQPSAVVL QCGADSLSGD RLGCFNLTVK GHAKCVEVVK TFNLPLLMLG 
    GGGYTIRNVA RCWTYETAVA LDCEIPNELP YNDYFEYFGP DFKLHISPSN MTNQNTPEYM 
    EKIKQRLFEN LRMLPHAPGV QMQAIPEDAV HEDSGDEDGE DPDKRISIRA SDKRIACDEE 
    FSDSEDEGEG GRRNVADHKK GAKKARIEED KKETEDKKTD VKEEDKSKDN SGEKTDTKGT 
    KSEQLSNP